FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to pharmaceutical composition and method of treating cognitive disorders. Pharmaceutical composition contains pharmaceutically effective cholinesterase inhibitor, selected from physostigmine and galantamine, and compound of formula I. Method of treating cognitive disorders involves introduction to patient pharmaceutical composition, containing cholinesterase inhibitor, selected from physostigmine and galantamine, and compound of formula I.
EFFECT: invention implementation provides effective treatment of cognitive disorders with insignificant side effects.
9 cl, 2 ex, 5 tbl, 3 dwg
Authors
Dates
2017-01-11—Published
2010-07-16—Filed